TMEM192 localizes to lysosomal/late endosomal membranes and influences cellular processes:
Knockdown Studies: Silencing TMEM192 in HepG2 hepatoma cells activates autophagy (LC3-II conversion) and apoptosis via mitochondrial pathways (Bax upregulation, caspase-3 activation) .
Murine Models: TMEM192-deficient mice exhibit normal lysosomal morphology and autophagic flux under basal conditions, suggesting compensatory mechanisms .
Ubiquitous Distribution: Highest expression in brain (hippocampus), kidney, spleen, and bone marrow .
Processing Specificity: The 17 kDa fragment is absent in liver, indicating tissue-dependent proteolysis .
Recombinant Xenopus laevis TMEM192 is utilized in:
TMEM192 homologs share conserved lysosomal targeting motifs but differ in processing:
KEGG: xla:446304
UniGene: Xl.19528
When comparing Xenopus laevis TMEM192 with mammalian orthologs, several important differences emerge:
| Feature | Xenopus laevis TMEM192 | Mouse TMEM192 | Human TMEM192 |
|---|---|---|---|
| Amino acid length | 261 aa | 266 aa | 271 aa |
| Dimerization | Unknown | Monomeric under non-reducing conditions | Forms homodimers via disulfide bridges |
| C-terminal cysteine | Absent | Absent | Present (C266) |
| Subcellular localization | Predicted lysosomal | Confirmed lysosomal (co-localizes with LAMP-2) | Confirmed lysosomal |
A significant difference is the absence of the C-terminal cysteine in Xenopus and mouse TMEM192 that is present in human TMEM192 (position 266). In human cells, this cysteine is involved in forming disulfide bridges between TMEM192 monomers, whereas mouse TMEM192 appears as a monomer even under non-reducing conditions . This structural difference may reflect species-specific functional adaptations.
Several expression systems have been successfully used for recombinant TMEM192 production:
| Expression System | Advantages | Limitations | Tag Options |
|---|---|---|---|
| E. coli | Cost-effective, high yield | May lack proper folding for transmembrane proteins | His, GST |
| Mammalian cells (HEK293) | Proper folding and post-translational modifications | Higher cost, lower yield | His, Fc, various fluorescent tags |
| Insect cells | Good for membrane proteins | Moderate cost | His, GST, various fusion tags |
| Yeast | Cost-effective for eukaryotic expression | May have different glycosylation patterns | His, various fusion tags |
For functional studies, expression in mammalian or insect cells is generally preferred to ensure proper folding and post-translational modifications of the transmembrane protein . For Xenopus laevis TMEM192 specifically, reported recombinant proteins have been produced in various systems including mammalian cells and E. coli .
Determining the subcellular localization of TMEM192 in Xenopus cells requires specialized approaches:
Immunofluorescence microscopy:
Generate specific antibodies against Xenopus TMEM192 (targeting N-terminal epitopes)
Co-stain with established lysosomal markers (e.g., LAMP-2)
Use super-resolution microscopy for detailed localization studies
Fractionation approaches:
Perform subcellular fractionation of Xenopus tissues or cells
Analyze fractions by Western blotting with TMEM192-specific antibodies
Compare distribution with known organelle markers
Live cell imaging:
Generate fluorescently-tagged TMEM192 constructs (N-terminal tagging recommended)
Express in Xenopus cells or embryos via microinjection
Co-express with established organelle markers
Based on studies in mouse cells, TMEM192 is expected to localize to lysosomes in Xenopus cells, but this requires experimental verification . When designing tagged constructs, it's important to note that N-terminal epitope tagging has been successfully used for mouse TMEM192 detection .
Several approaches are available for functional studies through gene manipulation:
| Approach | Advantages | Limitations | Time Frame |
|---|---|---|---|
| Morpholino oligonucleotides | Rapid, dose-adjustable, can target specific splice variants | Transient effect, potential off-target effects | Effects within 24-72 hours |
| CRISPR/Cas9 | Permanent modification, complete protein loss possible | More complex delivery, potential mosaicism | Requires F0/F1 screening |
| Dominant negative constructs | Can target specific protein functions | May have incomplete inhibition | Effects within 24-48 hours after expression |
| Photo-MO | Temporal control of knockdown | Requires UV activation, potentially less efficient | Light-activated as needed |
| Vivo-MO | Direct delivery to tissues without embryo manipulation | Limited to accessible tissues | Effects within 24-72 hours |
For Xenopus studies, antisense morpholinos have been extensively validated, with options including conventional MO (injected at 4-8 cell stage), photo-inducible MO (activated by 365 nm blue light), and vivo-MO (directly injected into tissue) . The choice depends on experimental requirements, particularly regarding the timing and tissue-specificity of knockdown.
To identify TMEM192 interactors in Xenopus:
Co-immunoprecipitation approaches:
Generate specific antibodies or use tagged TMEM192 constructs
Optimize lysis conditions for membrane protein extraction (detergent selection critical)
Validate interactions bidirectionally
Analyze by mass spectrometry
Proximity labeling methods:
Fuse TMEM192 with BioID or APEX2
Express in Xenopus embryos or cells
Identify proximal proteins through streptavidin pulldown and mass spectrometry
Yeast two-hybrid adaptations:
Use split-ubiquitin system designed for membrane proteins
Screen against Xenopus cDNA libraries
In vitro binding assays:
Express recombinant domains of TMEM192
Test direct interactions with candidate partners
Studies in other species have shown that immunoprecipitation of TMEM192 can successfully identify interacting partners. For example, in Xenopus egg extracts, centrosomal protein Cep192 was shown to co-immunoprecipitate with AurA , demonstrating the feasibility of such approaches in Xenopus systems.
Based on mammalian studies, TMEM192 likely functions in lysosomal biology in Xenopus. Experimental approaches to investigate this include:
Functional assays after TMEM192 perturbation:
Lysosomal pH measurement using ratiometric dyes
Lysosomal enzyme activity assays (e.g., cathepsin activity)
Autophagy flux monitoring (LC3-II/I ratio, p62 levels)
Lysosomal membrane stability assessment
Ultrastructural analysis:
Transmission electron microscopy of TMEM192-depleted cells
Immunogold labeling to localize TMEM192 in lysosomes
Morphological characterization of lysosomal compartments
In mouse studies, TMEM192 has been confirmed as a lysosomal membrane protein through co-localization with LAMP-2 . Additionally, research in human cells has identified TMEM192 as part of the lysosomal membrane proteome, potentially involved in lysosomal tubulation and sorting processes .
Exploring TMEM192's potential role in Xenopus regeneration:
Expression analysis during regeneration:
Compare TMEM192 expression between regenerating and non-regenerating tissues
Temporal expression profiling during regeneration phases
Spatial mapping in regenerating structures
Functional perturbation during regeneration:
Knockdown TMEM192 in regenerating tissues using morpholinos
Assess impact on regeneration rate and completeness
Rescue experiments with wild-type protein
Integration with known regeneration pathways:
Analyze relationship with established regeneration factors (e.g., Wnt, FGF, BMP)
Investigate links to lysosomal signaling during regeneration
Xenopus laevis provides an excellent model for regeneration studies, particularly tail regeneration in tadpoles . Recent research has highlighted the importance of lysosomes in early dorsal signaling and regenerative processes in Xenopus , suggesting TMEM192 could play a role in these processes given its lysosomal localization.
Structural characterization of Xenopus TMEM192 can provide functional insights:
Structural prediction and modeling:
Generate homology models based on related structures
Predict functional domains and interaction interfaces
Identify conserved structural motifs across species
Experimental structure determination:
Express and purify domains for X-ray crystallography
Use cryo-EM for full-length protein in membrane mimetics
Employ NMR for soluble domain structure determination
Structure-guided functional studies:
Design mutations targeting key structural elements
Perform structure-function correlation studies
Identify potential ligand-binding sites
Unlike human TMEM192, which forms disulfide-linked dimers, mouse TMEM192 exists primarily as a monomer due to the absence of the critical C-terminal cysteine (C266 in human) . Xenopus TMEM192 similarly lacks this cysteine, suggesting it may also function as a monomer, though this requires experimental confirmation.
When addressing contradictory findings across species:
Cross-species complementation:
Express Xenopus TMEM192 in mammalian knockout cells
Test if function is restored
Identify species-specific differences in activity
Domain swapping experiments:
Create chimeric proteins with domains from different species
Identify which regions confer species-specific properties
Map functional domains through systematic swapping
Comparative biochemical analysis:
Side-by-side functional assays under identical conditions
Detailed kinetic or binding parameter comparisons
Analysis of post-translational modifications across species
Context-dependent function testing:
Analyze function in different cellular contexts
Test under various physiological stresses
Examine developmental stage-specific functions
One notable difference already identified is that mouse TMEM192 does not form disulfide-linked dimers unlike its human counterpart . This raises questions about whether Xenopus TMEM192 behaves more like the mouse or human protein, and what functional implications these structural differences might have.
Translational applications of Xenopus TMEM192 research:
Disease modeling:
Generate Xenopus models with TMEM192 mutations mimicking human conditions
Analyze phenotypic outcomes relevant to lysosomal disorders
Test therapeutic interventions in these models
Pathway conservation analysis:
Compare lysosomal pathways between Xenopus and humans
Identify conserved elements that could be therapeutic targets
Determine species-specific differences that might limit translation
Drug screening platforms:
Develop Xenopus-based assays for compound screening
Assess effects on TMEM192-dependent processes
Validate hits in mammalian systems
Xenopus offers several advantages for disease modeling, including external development, easy manipulation, and conservation of many disease-relevant pathways . Recent studies have highlighted the importance of lysosomes in Xenopus development and signaling , providing context for investigating TMEM192's potential role in disease processes.
Robust experimental design requires appropriate controls:
| Experimental Approach | Essential Controls | Validation Methods |
|---|---|---|
| Antibody-based detection | Pre-immune serum controls, Peptide competition assays, TMEM192-depleted samples | Western blot, Immunoprecipitation, Mass spectrometry |
| Recombinant protein studies | Purification tag-only controls, Heat-denatured protein controls | SDS-PAGE purity assessment, Mass spectrometry verification |
| Knockdown/knockout studies | Scrambled/mismatch morpholinos, Rescue with morpholino-resistant constructs | RT-qPCR, Western blot, Phenotypic rescue |
| Localization studies | Multiple fixation methods, Co-localization with known markers | Pearson's correlation coefficient analysis |
When studying lysosomal functions related to TMEM192, appropriate controls include bafilomycin A1 treatment (which inhibits lysosomal acidification) and comparison with known lysosomal membrane proteins .
Developmental context considerations:
Stage-specific protein interactions:
Perform interaction studies at multiple developmental timepoints
Consider maternal versus zygotic protein pools
Account for changing cellular compositions of tissues
Temporal expression analysis:
Compare expression levels throughout development
Correlate with developmental transitions
Account for tissue-specific expression patterns
Functional redundancy assessment:
Identify potential compensatory mechanisms at different stages
Consider paralogs or functionally similar proteins
Perform combinatorial knockdown experiments
Xenopus development provides unique opportunities to study protein function across dramatically different cellular contexts, from early cleavage through metamorphosis . When interpreting data, researchers should consider that TMEM192 might have different binding partners or functions at different developmental stages.
Membrane protein-specific technical considerations:
Extraction and solubilization:
Screen multiple detergents (DDM, CHAPS, digitonin recommended for initial trials)
Optimize detergent-to-protein ratios
Consider detergent-free methods (SMALPs, nanodiscs)
Stability and storage:
Test multiple buffer conditions (pH 7.2-7.5 typically optimal)
Include stabilizers (glycerol, specific lipids)
Assess stability by size-exclusion chromatography
Functional reconstitution:
Incorporate into liposomes for transport studies
Use proteoliposomes for activity assays
Consider native membrane extraction approaches
Post-translational modification analysis:
Assess glycosylation status in different expression systems
Identify phosphorylation sites by mass spectrometry
Compare modification patterns with mammalian orthologs
Studies of mouse TMEM192 have successfully used detergent extraction followed by immunoprecipitation to study protein interactions , suggesting similar approaches would work for Xenopus TMEM192.